Mechanisms underlying mechanical responses to Ephedra herb of isolated rabbit urinary bladder and urethra, a possible stress urinary incontinence therapeutic

Journal of Pharmacological Sciences

Volumn 107, Issue 2, 2008, Pages 175-180

  Ayajiki, Kazuhide ^a   Kimura, Toshio ^b   Yamamizu, Kohei ^a   Okamura, Tomio ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Yasu Hospital   (Japan)

Author keywords

Arachidonic acid metabolite; Ephedra herb; Ephedrine; Stress urinary incontinence; Urethral contraction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ATROPINE; DEXCHLORPHENIRAMINE MALEATE; DOCEBENONE; EPHEDRA EXTRACT; EPHEDRINE; INDOMETACIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEPACRINE; METHYSERGIDE; MONTELUKAST; PRAZOSIN; TIMOLOL; YOHIMBINE; ZK 15252; ZK 158252;

ANIMAL TISSUE; ARTICLE; BLADDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG RESEARCH; FEMALE; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; NONHUMAN; RABBIT; SEX DIFFERENCE; STRESS INCONTINENCE; URETHRA; URINE INCONTINENCE;

EID: 46449119370     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08070FP     Document Type: Article

References (25)

1. Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc. 1998;46:473-480.
2. Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc. 2000;48:370-374.
3. Weiss BD. Selecting medications for the treatment of urinary incontinence. Am Fam Physician. 2005;71:315-322.
4. Salmon UJ, Walter RL, Geist S. The use of estrogen in the treatment of dysuria and incontinence in post-menopausal women. Am J Obstet Gynecol. 1941;42:845.
5. Fantl JA, Bump RC, Robinson D, McClish DK, Wyman JF. Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group. Obstet Gynecol. 1996;88:745-749.
6. Castro-Diaz D, Amoros MA. Pharmacotherapy for stress urinary incontinence. Curr Opin Urol. 2005;15:227-230.
7. Ozaki Y. Studies on antiinflammatory effect of Japanese Oriental medicines (kampo medicines) used to treat inflammatory diseases. Biol Pharm Bull. 1995;18:559-562.
8. Corcos J, Beaulieu S, Donovan J, Naughton M, Gotoh M. Symptom Quality of Life Assesment Committee of the First International Consultation on Incontinence: Quality of life assessment in men and women with urinary incontinence. J Urol. 2002;168:896-905.
9. Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's the pharmacological basis of therapeutics, 11th ed. New York: McGraw-Hill; 2006. p. 237-295.
10. Diokno AC, Taub M. Ephedrine in treatment of urinary incontinence. Urology. 1975;5:624-625.
11. Toda N, Hatano Y, Hayashi S. Modifications by stretches of the mechanical response of isolated cerebral and extracerebral arteries to vasoactive agents. Pflugers Arch. 1978;374:73-77.
12. Kishimoto T, Aoki K, Okamiya Y, Takeshita T, Naruchi T. Effects of clenbuterol on resting tension and contractile response in vesicourethral smooth muscle of rabbits. Jpn J Smooth Muscle Res. 1989;25:13-25.
13. Kimoto Y, Nozaki M, Itoh T. Actions of the alpha-1 adrenoceptor blocker bunazosin on the norepinephrine-induced contraction of smooth muscles in the rabbit proximal urethra. J Pharmacol Exp Ther. 1987;241:1017-1022.
14. Hashimoto S, Kigoshi S, Muramatsu I. Neurogenic responses of urethra isolated from the dog. Eur J Pharmacol. 1992;213:117-123.
15. Okamura T, Yamazaki M, Toda N. Responses to histamine and acetylcholine in isolated monkey mesenteric veins versus arteries. Cardiovasc Res. 1994;28:667-672.
16. Juan H, Sametz W. Histamine-induced release of arachidonic acid and of prostaglandins in the peripheral vascular bed: mode of action. Naunyn Schmiedebergs Arch Pharmacol. 1980;314:183-190.
17. Yoshimoto T, Yokoyama C, Ochi K, Yamamoto S, Maki Y, Ashida Y, et al. 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim Biophys Acta. 1982;713:470-473.
18. Matousek M, Mitsube K, Mikuni M, Brännström M. Inhibition of ovulation in the rat by a leukotriene B4 receptor antagonist. Mol Hum Reprod. 2001;7:35-42.
19. 2+ elevation and contraction of the human detrusor muscle. J Urol. 2003;170:638-644.
20. Anderson KE. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev. 1993;45:253-308.
21. Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol. 2003;170:649-653.
22. Yamaguchi T, Kitada S, Osada Y. Role of adrenoceptors in the proximal urethral function of female and male rabbits using an in vivo model of isovolumetric pressure generation. Neurourol Urodyn. 1993;12:49-57.
23. Willette RN, Sauermelch CF, Hieble JP. Role of alpha-1 and alpha-2 adrenoceptors in the sympathetic control of the proximal urethra. J Pharmacol Exp Ther. 1990;252:706-710.
24. Sudoh K, Inagaki O, Honda K. Responsiveness of smooth muscle in the lower urinary tract of rabbits to various agonists. Gen Pharmacol. 1997;28:629-631.
25. 4 in the guinea-pig lung involves a vascular component. Br J Pharmacol. 2004;141:449-456.